Market Insights Health Medical Technology Medical Devices

Diagnostic Imaging Devices - Southern Asia

Southern Asia

The Diagnostic Imaging Devices market market in Southern Asia is anticipated to achieve a revenue of US$0.83bn by 2024.
It is expected that the market will experience a steady annual growth rate (CAGR 2024-2029) of 5.99%, leading to a market volume of US$1.11bn by 2029.
When compared globally, the United States is projected to generate the highest revenue of US$11,930.00m in 2024.
In Southern Asia, the demand for advanced diagnostic imaging devices in the medical technology market is surging, driven by the growing need for accurate and timely diagnosis in the region's healthcare systems.

Key regions: Germany, Japan, Netherlands, Spain, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Diagnostic Imaging Devices market in Southern Asia is experiencing significant growth due to several factors.

Customer preferences: Customers in Southern Asia are increasingly demanding advanced and innovative diagnostic imaging devices that provide accurate and detailed results. They are seeking devices that offer high-resolution imaging, faster scanning times, and improved patient comfort. Additionally, there is a growing preference for portable and handheld imaging devices that can be used in remote areas or during emergencies.

Trends in the market: One of the key trends in the Diagnostic Imaging Devices market in Southern Asia is the adoption of digital imaging technology. Digital imaging offers several advantages over traditional film-based imaging, including faster image acquisition, enhanced image quality, and the ability to store and share images electronically. This trend is driven by the increasing need for efficient and streamlined healthcare processes, as well as the growing availability of affordable digital imaging devices. Another trend in the market is the rising demand for ultrasound devices. Ultrasound is a non-invasive imaging technique that uses high-frequency sound waves to create images of the internal organs. It is widely used in obstetrics and gynecology, cardiology, and other medical specialties. The increasing prevalence of chronic diseases, such as cardiovascular diseases and cancer, is driving the demand for ultrasound devices in Southern Asia.

Local special circumstances: Southern Asia is home to a large population, and the region is experiencing rapid urbanization and industrialization. This has led to an increase in lifestyle diseases, such as diabetes and obesity, which require regular diagnostic imaging for monitoring and treatment. Additionally, the region has a high prevalence of infectious diseases, such as tuberculosis and dengue fever, which also contribute to the demand for diagnostic imaging devices.

Underlying macroeconomic factors: The growing economy in Southern Asia is fueling the demand for healthcare services, including diagnostic imaging. As disposable incomes rise, people are more willing to spend on healthcare and medical procedures. Furthermore, governments in the region are investing in healthcare infrastructure and implementing healthcare reforms to improve access to quality healthcare services. These factors are driving the growth of the Diagnostic Imaging Devices market in Southern Asia. In conclusion, the Diagnostic Imaging Devices market in Southern Asia is witnessing significant growth due to customer preferences for advanced and innovative devices, the adoption of digital imaging technology, and the rising demand for ultrasound devices. The region's large population, rapid urbanization, and industrialization, as well as the growing economy and government investments in healthcare, are the underlying macroeconomic factors driving this growth.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.